OrbiMed’s Strongbridge Biopharma SBBP Stock Holding History
Bought
Maintained
Sold
OrbiMed's SBBP Position: Q4 2021 in Review
OrbiMed sold out of Strongbridge Biopharma (SBBP) in Q4 2021, closing a stake of 794,675 shares — an estimated $1.62M sold.
OrbiMed first reported a position in SBBP in Q3 2020 and held it in 5 quarters. The position peaked at $8.48M in Q4 2020. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.
- OrbiMed reported no remaining Strongbridge Biopharma position as of Q4 2021 after selling out during the quarter.
- OrbiMed sold 794,675 Strongbridge Biopharma shares in Q4 2021, an estimated $1.62M.
- OrbiMed first reported a position in Strongbridge Biopharma in Q3 2020 and held it in 5 quarters.
- OrbiMed's Strongbridge Biopharma position peaked at $8.48M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Strongbridge Biopharma as of Q4 2021.
Based on OrbiMed's 13F filing for Q4 2021, filed 14 Feb 2022.